David Chen
Director/Board Member at O-TA PRECISION INDUSTRY CO., LTD.
Profile
David S.
Chen is the founder of Summit Bridge Group, Inc. (founded in 2018).
He currently holds the position of Director at CDIB Capital Group since 2004, Independent Director at O-TA Precision Industry Co., Ltd.
since 2022, Independent Director at CCIF Acquisition Corp., and Senior Executive Vice President at CDIB Venture Capital Corp.
Dr. Chen previously held the position of Chief Executive Officer at Central Investment Holdings Co. Ltd.
from 1991 to 2000, Director at American Pharmaceutical Partners, Inc., Director at Abraxis BioScience, Inc. from 2007 to 2011, Executive Director at CDIB & Partners Investment Holding Corp., Director at China Development Financial Holding Corp., Director at Altek Corp., Director at Abraxis BioScience, Inc. from 1998 to 2007, and Vice President at General Motors China LLC from 2004 to 2011.
He has also pursued education at Stanford University (graduate), The California State University (MBA), Nova Southeastern University, Inc. (doctorate), Purdue University (graduate), the University of Michigan (doctorate), National Taiwan University (undergraduate), and East China Normal University (undergraduate).
David Chen active positions
| Companies | Position | Start |
|---|---|---|
| O-TA PRECISION INDUSTRY CO., LTD. | Director/Board Member | 2022-05-25 |
CCIF Acquisition Corp.
 CCIF Acquisition Corp. Financial ConglomeratesFinance CCIF Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 12, 2021 and is headquartered in New York, NY. | Director/Board Member | - |
CDIB Venture Capital Corp.
 CDIB Venture Capital Corp. Investment ManagersFinance CDIB Venture Capital Corp. is a venture capital subsidiary of China Development Financial Holding Corp. headquartered in Taipei, Taiwan. The firm was founded in 1999. | Chairman | - |
CDIB Capital Group
 CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Director/Board Member | 2009-05-03 |
Former positions of David Chen
| Companies | Position | End |
|---|---|---|
General Motors China LLC
 General Motors China LLC Motor VehiclesConsumer Durables Part of General Motors Co., General Motors China LLC is a Chinese company that manufactures and distributes automotive vehicles. The private company is based in Shanghai, China. | Corporate Officer/Principal | 2011-03-31 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Director/Board Member | 2011-03-29 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Director/Board Member | 2007-11-12 |
American Pharmaceutical Partners, Inc.
 American Pharmaceutical Partners, Inc. Pharmaceuticals: MajorHealth Technology American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL. | Director/Board Member | 2006-04-19 |
| Central Investment Holdings Co. Ltd. | President | 2000-01-31 |
Training of David Chen
| Stanford University | Graduate Degree |
| The California State University | Masters Business Admin |
| Nova Southeastern University, Inc. | Doctorate Degree |
| Purdue University | Graduate Degree |
| University of Michigan | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
| East China Normal University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CHINA DEVELOPMENT FINANCIAL HOLDING CORPORATION | Finance |
| O-TA PRECISION INDUSTRY CO., LTD. | Consumer Durables |
| ALTEK CORPORATION | Producer Manufacturing |
| Private companies | 11 |
|---|---|
American Pharmaceutical Partners, Inc.
American Pharmaceutical Partners, Inc. Pharmaceuticals: MajorHealth Technology American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL. | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
CDIB Capital Group
CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Finance |
CDIB & Partners Investment Holding Corp.
 CDIB & Partners Investment Holding Corp. Financial ConglomeratesFinance CDIB & Partners Investment Holding Corp. operates as an investment holding Taiwanese company. The private company is based in Taipei, Taiwan. and has subsidiaries in Singapore and Cayman Islands. The company was founded in 1998. The CEO is Chung Ling Chien. | Finance |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Microsoft (China) Co., Ltd.
 Microsoft (China) Co., Ltd. Packaged SoftwareTechnology Services Part of Microsoft Corp., Microsoft (China) Co., Ltd. is a Chinese company that provides a platform for software manufacturing and services. The private company is based in Beijing, China. Ralph Haupter has been the CEO of the company since 2012. | Technology Services |
| Central Investment Holdings Co. Ltd. | |
General Motors China LLC
General Motors China LLC Motor VehiclesConsumer Durables Part of General Motors Co., General Motors China LLC is a Chinese company that manufactures and distributes automotive vehicles. The private company is based in Shanghai, China. | Consumer Durables |
CCIF Acquisition Corp.
CCIF Acquisition Corp. Financial ConglomeratesFinance CCIF Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 12, 2021 and is headquartered in New York, NY. | Finance |
| Summit Bridge Group, Inc. | |
CDIB Venture Capital Corp.
CDIB Venture Capital Corp. Investment ManagersFinance CDIB Venture Capital Corp. is a venture capital subsidiary of China Development Financial Holding Corp. headquartered in Taipei, Taiwan. The firm was founded in 1999. | Finance |
- Stock Market
- Insiders
- David Chen
